A Teacher's Ordeal to Obtain Cancer Medication Keytruda from CCSS

In Costa Rica, the promise of accessible healthcare through the Caja Costarricense de Seguro Social (CCSS) is being tested for many patients battling serious illnesses. The case of Andrea Picado Zamora, a woman diagnosed with triple-negative breast cancer, exemplifies the arduous journey many must undertake to secure life-saving treatments like Keytruda, an immunotherapy drug.

Andrea's father, Víctor Picado, was forced into a month-long ordeal, navigating hospital corridors and bureaucratic channels, to obtain a formal written denial from the CCSS. This document was essential for Andrea to file an 'amparo' – a legal recourse to protect constitutional rights – which ultimately opened the door to her treatment. This highlights a critical flaw in the system: patients are often required to fight through administrative and legal battles simply to receive the care they are entitled to.

The situation underscores a broader concern about the efficiency and responsiveness of the CCSS in delivering timely and essential medical care. While the institution aims to provide universal healthcare, cases like Andrea's reveal the significant obstacles that can impede access to crucial medications. The struggle faced by the Picado family is a stark reminder of the human cost of bureaucratic delays and the urgent need for streamlined processes to ensure that all patients receive the treatment they need without undue hardship.